The following draft of certain rules further to amend Medical Device Rules, 2017, which the Central Government proposes

## Policy Analysis Report: Amendment to Medical Devices Rules, 2017 **1. Executive Summary:** This report analyzes a draft notification proposing amendments to the Medical Devices Rules, 2017, as published in the Gazette of India on February 5, 2021. The amendment, specifically related to rule 7 subrule 2, expands the accepted international standards for medical devices, potentially broadening the scope of compliance options for manufacturers. This amendment is intended to provide greater flexibility and potentially facilitate easier market access by recognizing additional international standards for medical device testing and certification. **2. Introduction:** This report provides an overview and analysis of a draft notification regarding amendments to the Medical Devices Rules, 2017. The analysis is based solely on the text provided in the Gazette of India publication dated February 5, 2021. The purpose is to inform stakeholders, particularly those in the medical device industry, about the proposed changes and their potential implications. **3. Policy Overview:** * This analysis concerns an *amendment* to the existing Medical Devices Rules, 2017. * **Core Objective(s):** The objective, as inferred from the provided text, is to update and refine the Medical Devices Rules, 2017, to potentially broaden the range of acceptable testing standards for medical devices in India. This could streamline compliance processes and promote innovation. **4. Background and Rationale:** The amendment adds "or American Standard Test Method ASTM" to the existing acceptance of the International Electro Technical Commission (IEC) standards within the Medical Devices Rules, 2017. The likely reason for this specific amendment is to offer medical device manufacturers alternative, yet recognized, international standards for compliance. This could address situations where ASTM standards are more relevant or accessible for certain types of medical devices, thus potentially reducing regulatory burden and fostering a more competitive environment. **5. Key Provisions / Changes:** * **Specific Part of Original Policy Changed:** Rule 7, subrule 2 of the Medical Devices Rules, 2017. * **New Rule/Provision:** The amendment adds the phrase "or American Standard Test Method ASTM" after "the International Electro Technical Commission IEC" in Rule 7, subrule 2. * **Difference/Effect of Change:** This change broadens the scope of acceptable testing and certification standards for medical devices. Previously, compliance might have been primarily focused on IEC standards. Now, manufacturers can also demonstrate compliance using ASTM standards, providing flexibility and potentially reducing costs associated with adhering to a single standard. It suggests that medical devices can now be approved if they meet *either* IEC or ASTM standards. **6. Target Audience and Stakeholders:** The primary target audience and stakeholders are: * Medical device manufacturers (both domestic and international) who intend to market their products in India. * Regulatory bodies responsible for approving and monitoring medical devices. * Testing and certification agencies involved in assessing medical device compliance. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The Ministry of Health and Family Welfare (Department of Health and Family Welfare) is the responsible agency. The Drugs Technical Advisory Board was consulted in the drafting of these rules. * **Timelines/Procedures:** The draft rules were published on February 5, 2021. A period of forty-five days was provided for public comment and suggestions. It can be inferred that after this period, the Central Government would consider feedback and finalize the amendments. * **Implementation of Changes:** Manufacturers will now need to ensure their devices meet either IEC or ASTM standards to comply with Rule 7(2). Regulatory bodies will need to be prepared to assess compliance based on either standard. **8. Expected Outcomes / Impact of Changes:** The likely intended outcome of these specific changes is: * Increased flexibility for medical device manufacturers in demonstrating compliance. * Potentially reduced regulatory burden and faster approval times for certain medical devices. * Promotion of innovation and competition in the medical device industry by accepting a wider range of internationally recognized standards. * Harmonization with international best practices by recognizing ASTM standards. **9. Conclusion:** The proposed amendment to the Medical Devices Rules, 2017, published on February 5, 2021, represents a potentially significant update. By including American Standard Test Method (ASTM) alongside the International Electro Technical Commission (IEC) standards, the amendment provides greater flexibility for manufacturers, potentially reduces regulatory hurdles, and promotes innovation within the medical device sector. The changes are likely to have a positive impact on the industry by broadening the scope of accepted international standards and harmonizing regulatory practices.

Key Entities Referenced